ClinicalTrials.govpublic full text
Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
hiv infections, tuberculosis, hiv, pharmacokinetics, raltegravir, france, brazil, treatment naive, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 867575
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.